D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Recruiting · NCT06643208 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm | Recruiting | Not stated | 2025-06-26 | NCT06643208 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fujian Provincial Hospital | 45 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Provincial Hospital | Fuzhou | China | 14 |